Biologically Inspired Engineering, synbio, synthetic biology, crispr
According to a report by the World Bank, China is well advanced in building a national innovation system (NIS) capable of supplying the innovation and technologies needed for a growing economy that is productivity-led. Currently, the country’s NIS focuses on discovering new innovations and accelerating the diffusion of technologies throughout to support a rapidly increasing … Read more
The U.S. military believes the key to finding a vaccine or effective treatment against COVID-19 may lie in its genetic code. Researchers around the globe are searching for clues to unlock the secrets of the novel coronavirus as the epidemic continues to spread worldwide. The Air Force Genetics Center of Excellence at Keesler Air Force … Read more
BeiGene was founded nearly ten years ago in China. Today, the company a lot more than a cute-sounding name. It is a commercial-stage, publicly-traded biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The Chinese biotech giant raised $2 billion in a registered direct offering in July. … Read more
According to Loncar Funds, biotechnology innovation matters. Whether it is a cure for hepatitis C, new advances in cancer care, or progress against rare and debilitating diseases like cystic fibrosis, patients around the world are benefiting from unprecedented innovation that the biotech industry is delivering. Loncar Funds attributes this innovation to precision medicine. As the … Read more
Two research teams recently reported results from studies involving the long-term evaluation of non-invasive DNA fragments in blood. Evaluating these DNA fragments is called liquid biopsy, and this type of biopsy could vastly improve outcomes through early detection and low false positive rates for a wide variety of cancers. One result is Chinese and the … Read more
Concerto HealthAI, a SymphonyAI Group portfolio company, is innovating in real world data (RWD) and AI solutions for precision oncology. The company’s mission is to bring together unique data assets, AI-based technologies, and top outcomes research and data science talent. Concerto HealthAI’s focus is on revolutionizing clinical and outcomes research to accelerate the insights benefiting … Read more
The Food and Drug Administration (FDA) uses real world data (RWD) and real world evidence (RWE) to monitor postmarket safety and adverse events – and also to make regulatory decisions. The 21st Century Cures Act, passed in 2016, places additional focus on the use of these types of data to support regulatory decision making, including … Read more
It all began with an unexpected discovery. CureVac’s founder, Dr. Ingmar Hoerr (a doctoral student at the time), discovered that when it was administered directly into tissue, the historically unstable biomolecule mRNA could be used as a therapeutic vaccine or agent after optimization—no complicated reformulations or molecular packaging needed. With a single discovery, CureVac opened … Read more
Engineering biological systems to solve problems is becoming almost commonplace. Ideas range from finding environmentally sustainable ways to mimic natural resources to building new kinds of medical treatments for deadly diseases. The enormous promise of such work is rapidly intercepting with actual results. When physicist David Ross thinks of these things, he thinks a lot … Read more
Admetsys is developing what can be described as an artificial pancreas for patients requiring precise glucose control in a hospital setting. I spoke with Jeff Valk, CEO, who aptly walked me through his company’s technology and its vital importance for, “The most metabolically variable humans on earth.” To put at-risk patients on a solid ground … Read more